Prevention in Belgian Hockey : What Does the Staff Really Put in Place?

January 2, 2024 updated by: Gofflot Amandine, University of Liege

Purpose: To provide an update on the implementation of prevention among hockey players by their entourage.

Materiel and method: This study will be conducted by the means of a questionnaire. The target population consisted of trainers.

The questionnaire will be validated by experts and published on an online survey website

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Belgium
      • Liège, Belgium, 4000
        • Recruiting
        • University of Liege
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Hockey trainer at different level of play

Description

Inclusion Criteria:

  • Professions: hockey trainer

Exclusion Criteria:

  • /

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Trainers
Other: Primary prevention
The primary prevention that the trainers put in place for the hockey players

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Primary prevention by a questionnaire
Time Frame: Time Frame: The questionnaire will last 15 minutes at most
The trainers will respond to a questionnaire that will inform us about the primary prevention that they put in place in hockey.
Time Frame: The questionnaire will last 15 minutes at most

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Liege

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2021

Primary Completion (Estimated)

June 1, 2024

Study Completion (Estimated)

July 1, 2024

Study Registration Dates

First Submitted

July 13, 2021

First Submitted That Met QC Criteria

July 22, 2021

First Posted (Actual)

July 26, 2021

Study Record Updates

Last Update Posted (Estimated)

January 3, 2024

Last Update Submitted That Met QC Criteria

January 2, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 160521

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Primary Prevention

Clinical Trials on Primary prevention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe